Santiago de Compostela University Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2017
NCT02783404
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

M.J. López-Valladares, PhD, University Hospital Complex of Santiago de Compostela, Spain

Active Ingredients

Drugs in Phase 4 Trials (2)

clavulanate (Augmentin) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacteremia (Phase 4)

Endocarditis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2